Literature DB >> 30190042

Investigating post-stroke fatigue: An individual participant data meta-analysis.

Toby B Cumming1, Ai Beng Yeo2, Jodie Marquez2, Leonid Churilov3, Jean-Marie Annoni4, Umaru Badaru5, Nastaran Ghotbi6, Joe Harbison7, Gert Kwakkel8, Anners Lerdal9, Roger Mills10, Halvor Naess11, Harald Nyland12, Arlene Schmid13, Wai Kwong Tang14, Benjamin Tseng15, Ingrid van de Port16, Gillian Mead17, Coralie English18.   

Abstract

OBJECTIVE: The prevalence of post-stroke fatigue differs widely across studies, and reasons for such divergence are unclear. We aimed to collate individual data on post-stroke fatigue from multiple studies to facilitate high-powered meta-analysis, thus increasing our understanding of this complex phenomenon.
METHODS: We conducted an Individual Participant Data (IPD) meta-analysis on post-stroke fatigue and its associated factors. The starting point was our 2016 systematic review and meta-analysis of post-stroke fatigue prevalence, which included 24 studies that used the Fatigue Severity Scale (FSS). Study authors were asked to provide anonymised raw data on the following pre-identified variables: (i) FSS score, (ii) age, (iii) sex, (iv) time post-stroke, (v) depressive symptoms, (vi) stroke severity, (vii) disability, and (viii) stroke type. Linear regression analyses with FSS total score as the dependent variable, clustered by study, were conducted.
RESULTS: We obtained data from 14 of the 24 studies, and 12 datasets were suitable for IPD meta-analysis (total n = 2102). Higher levels of fatigue were independently associated with female sex (coeff. = 2.13, 95% CI 0.44-3.82, p = 0.023), depressive symptoms (coeff. = 7.90, 95% CI 1.76-14.04, p = 0.021), longer time since stroke (coeff. = 10.38, 95% CI 4.35-16.41, p = 0.007) and greater disability (coeff. = 4.16, 95% CI 1.52-6.81, p = 0.010). While there was no linear association between fatigue and age, a cubic relationship was identified (p < 0.001), with fatigue peaks in mid-life and the oldest old.
CONCLUSION: Use of IPD meta-analysis gave us the power to identify novel factors associated with fatigue, such as longer time since stroke, as well as a non-linear relationship with age.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Fatigue; Fatigue Severity Scale; Individual data; Meta-analysis; Stroke

Mesh:

Year:  2018        PMID: 30190042     DOI: 10.1016/j.jpsychores.2018.08.006

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  6 in total

1.  Post-stroke fatigue: a scoping review.

Authors:  Ghazaleh Aali; Avril Drummond; Roshan das Nair; Farhad Shokraneh
Journal:  F1000Res       Date:  2020-04-07

2.  Post-stroke fatigue: an exploratory study with patients and health professionals to develop a patient-reported outcome measure.

Authors:  Ingrid Johansen Skogestad; Marit Kirkevold; Petra Larsson; Christine Råheim Borge; Bent Indredavik; Caryl L Gay; Anners Lerdal
Journal:  J Patient Rep Outcomes       Date:  2021-04-21

3.  The Neurobiology of Pathological Fatigue: New Models, New Questions.

Authors:  Annapoorna Kuppuswamy
Journal:  Neuroscientist       Date:  2021-01-15       Impact factor: 7.235

Review 4.  No add-on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham-controlled trial combining tDCS with computerized cognitive training.

Authors:  Kristine M Ulrichsen; Knut K Kolskår; Geneviève Richard; Mads Lund Pedersen; Dag Alnaes; Erlend S Dørum; Anne-Marthe Sanders; Sveinung Tornås; Luigi A Maglanoc; Andreas Engvig; Hege Ihle-Hansen; Jan E Nordvik; Lars T Westlye
Journal:  Brain Behav       Date:  2022-06-06       Impact factor: 3.405

5.  Perspectives and Experiences of Cardiac Rehabilitation after Stroke-A Qualitative Study.

Authors:  Olive Lennon; Alexandra Crystal; Michelle Kwan; Caoimhe Tierney; Anne Gallagher; Sean Murphy
Journal:  Healthcare (Basel)       Date:  2022-08-19

6.  Differences in outcomes following an intensive upper-limb rehabilitation program for patients with common central nervous system-acting drug prescriptions.

Authors:  Ainslie Johnstone; Fran Brander; Kate Kelly; Sven Bestmann; Nick Ward
Journal:  Int J Stroke       Date:  2021-04-09       Impact factor: 5.266

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.